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Abstract 
Calculations carried out to generate dissolution profile data are complicated and subject to error to be performed 
manually, moreover and due to the repetitive nature of the dissolution testing experiments it is necessary to create a 
validated spreadsheet to replace and overcome the problems associated with manual calculations. A simple, user friendly 
spreadsheet was written to calculate dissolution profiles for a dissolution experiment where the volume of the dissolution 
medium for the vessel varies with time as the removed dissolution medium is not replaced with fresh one at each time 
point. The calculations of the spreadsheet were validated against manual calculations using a hand-held calculator; the 
results of the two methods were found to be comparable. The developed spreadsheet can be easily adapted for use in 
regulated environment after activating the security features embedded in Microsoft Excel software such as formulae hiding, 
cells block and password protection.   
Keywords: Spreadsheet, Dissolution profiles calculation without media replacement. 
 
1. Introduction 
In vitro dissolution testing provides useful 
information at several stages of drug development process. 
Formulation scientists use dissolution to assess the 
dissolution properties of the drug itself and thereby by 
select appropriate excipients for the formulation. 
Dissolution testing is also employed to assist in choosing 
among candidate formulations, with the aim of selecting the 
dosage form with the most suitable and reproducible release 
profile. Dissolution tests are also used to establish in vivo/in 
vitro correlation between release of drug from dosage form 
and drug absorption [1].  
Dissolution testing is also used to assure quality of 
the manufactured products and to ensure batch to batch 
reproducibility and adequate performance throughout their 
shelf lives [2]. 
In addition, there has been increasingly more 
interest in replacing single point test requirements with 
dissolution profiles containing multiple time points [3,4]. 
When sampling is carried out at multiple time 
points there are three potential scenarios: 
 The sample is removed from the dissolution vessel and 
no replacement media is added resulting in a reduction 
in the dissolution volume.  
 The sample is removed from the dissolution vessel and 
replacement media is added, resulting in the media 
volume remaining unchanged but there is a reduction in 
the concentration of the drug in the dissolution media in 
the dissolution vessel.   
 The sample is returned to the dissolution vessel after 
analysis. This results in no changes to the dissolution 
volume or the concentration of the drug in the 
dissolution media. 
In both of the first two scenarios it is necessary to 
take into account the amount of drug removed from the 
dissolution at previous time points in order obtain accurate 
release profiles. In the first scenario it is also necessary to 
take into account the changing dissolution volume. 
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The use of Excel spreadsheets in a regulated 
environment (cGXP = GMP, GLP, GCP) has to be 
controlled and validated. Also, periodic revalidation after 
defined intervals or changes has to be performed. This is 
consistent with EC guides on Good Manufacturing Practice 
(chapter 6.7, “Documentation” [5] and chapter 6.16, 
“Testing” [6]) and the FDA 21 CFR Part 11 electronic 
records and electronic signatures regulation [7]. 
Calculations carried out to generate dissolution 
profile data are complicated and subject to error to be 
performed manually, moreover and due to the repetitive 
nature of the dissolution testing experiments it is necessary 
to create a validated spreadsheet to replace and overcome 
the problems associated with manual calculations.  
This spreadsheet will be written for a dissolution 
experiment where the volume of the dissolution medium for 
the vessel varies with time as the removed dissolution 
medium is not replaced with fresh one at each time point.  
The sheet will assist in calculating the amount 
dissolved and the percent dissolved values when multiple 
time points are being measured in a dissolution profile 
study. The spreadsheet corrects for the amount of dissolved 
drug substance removed at each time point and reports 
results in terms of percent of label claim dissolved for each 
vessel. The spreadsheet also calculates the mean percent 
dissolved, standard deviation, and percent relative standard 
deviation for each time point. 
To ensure the spreadsheet security, the ability to enter the 
document and edit protected cells will be controlled by a 
password. The spreadsheet portion which performs the 
calculations consists of protected and locked cells. Other 
sections of the document where data are entered are not 
protected and will allow the analyst to enter data. The cells 
where data are to be entered will be shaded using simple 
Excel commands; when writing the spreadsheet in order to 
assist the analyst in locating the data input cells. 
 
2. Methods 
The spreadsheet was originally created by making 
column B (vessel l), and then column B was filled across 
automatically using the appropriate Excel command to 
create columns for vessels 2 through 12. Data were input 
into the spreadsheet and concurrent manual calculations 
were carried out and shown to correspond to the computer 
outputs for time point 1 of vessel 1 through vessel 12. 
The calculations of the spreadsheet were validated 
against manual calculations using a hand-held calculator 
(fx-100MS Casio Scientific Calculator). The formulas used 
for the manual calculations are shown below: 
T 1 % dissolved = ((((A1 xV)/As) x C x D) x W) x100 
T 2 % dissolved = (((((A2 x (V- (P x n-1))) + (A1 x P))/As) x 
C x D) x W) x100 
T 3 % dissolved = (((((A3 x (V- (P x n-1))) + (A1 + A2) x 
P))/As) x C x D) x W) x100 
T n % dissolved = (((((An x (V- (P x n-1))) + (An-1 + A n-2 + 
…..) x P))/As) x C x D) x W) x100 
Where, 
A1 = the absorbance or analytical response of the first sample pull 
A2 = the absorbance or analytical response of the second sample pull 
An = the absorbance or analytical response of the n
th
 sample pull 
As = the average absorbance or analytical response of the standard 
V = the initial media volume, ml 
C = the concentration of the standard, mg/ml 
W = the dose strength of the sample, mg 
P = the volume of media being withdrawn for a single sample pull, 
ml 
D = the withdrawn sample dilution factor (if diluted after pulling) 
n = the number of the sample pull taken 
 
3. Results 
A spreadsheet entitled “Calculation of Dissolution 
Profiles” was written to perform dissolution calculations 
using Microsoft Excel software. Table l displays a portion 
of the spreadsheet with sample information entered for a 
hypothetical dissolution experiment.  
 
Dissolution Profile Analysis 
Enter data into shaded area 
 Product Name: XYZ 
Strength(mg) 40 
Volume (ml) 900 
Standard concn.(mg/ml) 0.008 
Average std response 0.434 
Sample pull volume (ml) 20.00 
Sample dilution factor 5 
 
Samples responses 
Sample pull No. 
Vessel number 
1 
1 0.364 
2 0.462 
3 0.482 
4 0.488 
5 0.495 
6 0.499 
Results:   
mg removed  
 
Vessel number 
Time (minutes) 1 
10 0.671 
20 0.840 
30 0.883 
40 0.893 
50 0.905 
60 0.911 
 
Table 1: Spreadsheet used for dissolution calculations 
with data for a hypothetical dissolution experiment 
The percent dissolved result cells for times 2 
through 6 were originally made by using Excel fill down, 
and therefore a check of time 6 was made to assure that all 
lines were correct. 
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The accuracy of the columns was validated by 
inputting the data from vessel 1 in each of the other 
columns to ensure that the generated results were the same 
for each vessel. 
Table 2 displays a printout of the spreadsheet 
formulas for vessel 1. From this printout, these basic 
formulas were used to build an entire template for as many 
vessels as required. 
To further ensure the accuracy of the calculation a 
hypothetical dissolution profile calculation was carried out 
for 12 vessels with 6 pulls of the samples from each vessel 
spanning from 10-60 minutes, the input data of vessels 4, 2 
and 3 were intentionally used again as data for vessels 7, 11 
and 12 respectively, the results of these each vessel were in 
full agreement with its corresponding one, Table 3 displays 
the data calculated for the twelve vessels as well as the 
mean percent dissolved, standard deviation(Stdv.), and 
percent relative standard deviation (RSD%) for each time 
point.  
 
Results: 
  
mg removed 
 
 
Vessel number 
Time (minutes) 1 
10 =B15/$B$9*$B$8*$B$11*$B$10 
20 =((((B16*($B$7-($B$10*($A$17-1))+(B15*$B$10))/$B$9)*$B$8)*$B$11*$B$10/$B$7)) 
30 =((((B17*($B$7-($B$10*($A$18-1)))+((B15+B16)*$B$10))/$B$9)*$B$8)*$B$11*$B$10/$B$7) 
40 =((((B18*($B$7-($B$10*($A$19-1)))+((B15+B16+B17)*$B$10))/$B$9)*$B$8)*$B$11*$B$10/$B$7) 
50 =((((B19*($B$7-($B$10*($A$20-1)))+((B15+B16+B17+B18)*$B$10))/$B$9)*$B$8)*$B$11*$B$10/$B$7) 
60 =((((B20*($B$7-($B$10*($A$21-1)))+((B15+B16+B17+B18+B19)*$B$10))/$B$9)*$B$8)*$B$11*$B$10/$B$7) 
Fraction dissolved % 
 
 
Vessel number 
Time (minutes) 1 
10 =((((B15*$B$7/$B$9)*$B$8*$B$11/$B$6)*100)) 
20 =((((B16*($B$7-($B$10*($A$17-1))+(B15*$B$10))/$B$9)*$B$8)*$B$11/$B$6)*100) 
30 =((((B17*($B$7-($B$10*($A$18-1)))+((B15+B16)*$B$10))/$B$9)*$B$8)*$B$11/$B$6*100) 
40 =((((B18*($B$7-($B$10*($A$19-1)))+((B15+B16+B17)*$B$10))/$B$9)*$B$8)*$B$11/$B$6)*100 
50 =((((B19*($B$7-($B$10*($A$20-1)))+((B15+B16+B17+B18)*$B$10))/$B$9)*$B$8)*$B$11/$B$6)*100 
60 =((((B20*($B$7-($B$10*($A$21-1)))+((B15+B16+B17+B18+B19)*$B$10))/$B$9)*$B$8)*$B$11/$B$6)*100 
 
Table 2: Spreadsheet printout showing formulas used for calculation of results for vessel 
 
mg removed 
      
      
 
Vessel number 
Time (minutes) 1 2 3 4 5 6 7 8 9 10 11 12 
10 0.671 0.662 0.664 0.643 0.636 0.623 0.643 0.636 0.623 0.671 0.662 0.664 
20 0.840 0.839 0.870 0.812 0.845 0.792 0.812 0.845 0.792 0.840 0.839 0.870 
30 0.883 0.869 0.875 0.869 0.868 0.877 0.869 0.868 0.877 0.883 0.869 0.875 
40 0.893 0.882 0.888 0.880 0.885 0.872 0.880 0.885 0.872 0.893 0.882 0.888 
50 0.905 0.877 0.892 0.890 0.895 0.890 0.890 0.895 0.890 0.905 0.877 0.892 
60 0.911 0.892 0.897 0.903 0.905 0.904 0.903 0.904 0.920 0.905 0.892 0.897 
Fraction dissolved % 
            
 
Vessel number 
Time (minutes) 1 2 3 4 5 6 7 8 9 10 11 12 
10 75.48 74.45 74.65 72.37 71.54 70.09 72.37 71.54 70.09 75.48 74.45 74.65 
20 94.45 94.44 97.92 91.35 95.03 89.08 91.35 95.03 89.08 94.45 94.44 97.92 
30 99.32 97.71 98.39 97.79 97.66 98.68 97.79 97.66 98.68 99.32 97.71 98.39 
40 100.48 99.26 99.94 98.95 99.59 98.10 98.95 99.59 98.10 100.48 99.26 99.94 
50 101.80 98.69 100.31 100.09 100.73 100.18 100.09 100.73 100.18 101.80 98.69 100.31 
60 102.54 100.35 100.87 101.56 101.83 101.65 101.56 101.65 103.50 101.80 100.35 100.87 
  
Mean Stdv.   %RSD 
        
 
10 73.10 2.00 2.73 
        
 
20 93.71 2.94 3.14 
        
 
30 98.26 0.63 0.64 
        
 
40 99.39 0.79 0.79 
        
 
50 100.30 0.96 0.96 
        
 
60 101.54 0.89 0.88 
         
Table 3: The data calculated for the twelve vessels, the mean percent dissolved, standard deviation and percent 
relative standard deviation for each time point. 
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4. Conclusion 
The use of spreadsheets is a very helpful tool for 
data-organization, data-entry and data-calculations as such 
it is greatly enhancing the productivity of the laboratory.  
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